| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/05/1992 | WO1992003733A1 Methods and compositions for early detection and treatment of insulin dependent diabetes mellitus |
| 03/05/1992 | WO1992003578A1 In vitro retroviral integration assay |
| 03/05/1992 | WO1992003569A1 Protein polyligands joined to a stable protein core |
| 03/05/1992 | WO1992003568A1 Sugar modified oligonucleotides that detect and modulate gene expression |
| 03/05/1992 | WO1992003566A1 Therapeutic ribozyme compositions |
| 03/05/1992 | WO1992003550A1 Ryegrass pollen allergen |
| 03/05/1992 | WO1992003548A1 Human zona pellucida protein zp3 |
| 03/05/1992 | WO1992003547A1 MAREK'S DISEASE HERPESVIRUS DNA SEGMENT ENCODING GLYCOPROTEINS, gD, gI AND gE |
| 03/05/1992 | WO1992003535A1 Recombinant bpi proteins, uses of bpi proteins, and methods of preparing same |
| 03/05/1992 | WO1992003479A1 Replication initiator protein complex and methods of use thereof |
| 03/05/1992 | WO1992003474A1 METHOD OF INTERFERING WITH FORMATION OF α-ANTICHYMOTRYPSIN-β-PROTEIN COMPLEX AND SYNTHETIC PEPTIDES FOR USE THEREIN |
| 03/05/1992 | WO1992003472A1 Peptides containing amino-polyols as transition-state mimics |
| 03/05/1992 | WO1992003457A1 Entamoeba histolytica immunodominant surface antigens |
| 03/05/1992 | WO1992003456A1 Oligonucleotides for modulating the effects of cytomegalovirus infections |
| 03/05/1992 | WO1992003165A1 New use of a monoclonal antibody |
| 03/05/1992 | WO1992003164A1 Neuraminidase and galactose oxidase as vaccine adjuvant |
| 03/05/1992 | WO1992003155A1 Product containing growth factor and glutamine and use of growth factor for the treatment of intestinal mucosa |
| 03/05/1992 | WO1992003154A1 Product and use of it for the treatment of catabolic states comprising authentic igf-1 and hypocaloric amount of nutritients |
| 03/05/1992 | WO1992003153A1 Hemoglobin-oligomer based composition and method to make same |
| 03/05/1992 | WO1992003151A1 Uses of recombinant colony stimulating factor-1 |
| 03/05/1992 | WO1992003150A1 Cell density signal molecule isolated from embryonic tendon cells |
| 03/05/1992 | WO1992003149A1 Superior thrombomodulin analogs for pharmaceutical use |
| 03/05/1992 | WO1992003147A1 Peptides that block human immunodeficiency virus infections and methods of use thereof |
| 03/05/1992 | WO1992003146A1 Therapeutically active mixture of glutathion and anthocyan compounds |
| 03/05/1992 | WO1992003139A1 Oligonucleotide modulation of cell adhesion |
| 03/05/1992 | WO1992003049A1 Methods and compositions for treating t-cell mediated diseases |
| 03/05/1992 | WO1992001794A3 Ancrod-like proteins, their preparation and their use |
| 03/05/1992 | WO1991015516A3 Hepatitis c virus epitopes |
| 03/05/1992 | DE4027154A1 Mutation der hrv2 2a Mutation of HRV2 2a |
| 03/05/1992 | DE4019208A1 Nervenregenerationsmittel Nerve regeneration agent |
| 03/05/1992 | CA2648350A1 Superior thrombomodulin analogs for pharmaceutical use |
| 03/05/1992 | CA2090689A1 Regulation of t-cell proliferation via a novel 5htla receptor |
| 03/05/1992 | CA2090688A1 Regulation of neoplastic cell proliferation via a novel 5htla receptor |
| 03/05/1992 | CA2090105A1 Protein polyligands joined to a stable protein core |
| 03/05/1992 | CA2089257A1 Product containing growth factor and glutamine and use of growth factor for the treatment of intestinal mucosa |
| 03/05/1992 | CA2088674A1 Product and use of it for the treatment of catabolic states comprising authentic igf-1 and hypocaloric amount of nutrients |
| 03/05/1992 | CA2081770A1 A cd58-specific monoclonal antibody and the use thereof |
| 03/05/1992 | CA2072871A1 Preservation of blood, tissues and biological fluids |
| 03/05/1992 | CA2067241A1 Hemoglobin-oligomer based composition and method to make same |
| 03/05/1992 | CA2066160A1 Marek's disease herpesvirus dna segment encoding glycoproteins, gd, gi and ge |
| 03/05/1992 | CA2050434A1 Renin inhibitors |
| 03/05/1992 | CA2048699A1 Method for preventing or treating cerebro-vascular disease employing ceronapril |
| 03/04/1992 | EP0473564A1 Anticoagulant combination of laci and sulfated polysaccharides |
| 03/04/1992 | EP0473337A2 Nor-statine and nor-cyclostatine polypeptides in the treatment of ocular hypertension and glaucoma |
| 03/04/1992 | EP0473268A2 Continuous release pharmaceutical compositions comprising a polypeptide covalently conjugated to a water soluble polymer |
| 03/04/1992 | EP0473145A1 Compositions for inhibiting aminoglycoside nephrotoxicity |
| 03/04/1992 | EP0473128A2 Monoclonal antibody specifically reactive with human perforin |
| 03/04/1992 | EP0473111A2 Recombinant mite allergen |
| 03/04/1992 | EP0473080A2 Chondromodulin-I protein |
| 03/04/1992 | EP0472987A1 Antimicrobial peptides active against plant pathogens, their use and screening methods pertaining thereto |
| 03/04/1992 | EP0472725A1 Treatment of polycystic ovarian disease. |
| 03/04/1992 | EP0472670A1 Symmetrical bipeptides including a polyalkylene-gylcol group, method of preparation and use in protease determination. |
| 03/04/1992 | EP0472638A1 Method for isolating receptors having a preselected specificity |
| 03/04/1992 | EP0472588A1 Composition and method for reducing gastro-intestinal distress due to alpha-d-galactoside-linked/containing sugars. |
| 03/04/1992 | CA2050425A1 Pharmaceutical composition and its mucous use |
| 03/03/1992 | US5093531 Polyethylene glycol substituted phenyl glyoxals |
| 03/03/1992 | US5093322 Tick-derived amblyommin and method of antithrombin therapy |
| 03/03/1992 | US5093320 Immunosuppressants |
| 03/03/1992 | US5093317 Treating disorders by application of insulin-like growth factor |
| 03/03/1992 | US5093316 Inhalation of alpha-1-antitrypsin and other serine protease inhibitors |
| 03/03/1992 | US5093315 Aqueous solutions or solids |
| 03/03/1992 | US5093265 Method for detecting of premenstrual syndrome |
| 03/03/1992 | US5093233 Antagonists with position 13 modification |
| 03/03/1992 | US5093143 Dietetic nutrient compositions for patients with kidney insufficiency |
| 03/03/1992 | US5093129 Method for treating addiction to a drug of abuse employing an ace inhibitor |
| 03/03/1992 | US5093127 Cyclodextrin Carrier, Antiallergens |
| 03/03/1992 | US5093117 Compositions and method for the treatment or prophylaxis of sepsis or septic shock |
| 03/03/1992 | US5093116 Method of treating viral infection utilizing inteferon α and pipyridamole |
| 03/03/1992 | US5093114 Treatment of human viral infections |
| 03/03/1992 | US5092885 Antitumor agents, wouond healing agents, promoters of cell adhesion to prostheses |
| 03/03/1992 | US5092876 Cell attachment peptides derived from amyloid P component |
| 03/03/1992 | CA1296669C Substance gif-2 and process for production of the same |
| 03/03/1992 | CA1296667C Process for preparing lymphokine activated killer cells |
| 03/03/1992 | CA1296640C Special lipid mixture for membrane fluidization |
| 03/03/1992 | CA1296639C Agent for treatment of kidney diseases |
| 03/03/1992 | CA1296638C Agent for prophylaxis and treatment of heart failure |
| 03/03/1992 | CA1296627C Compositions for parenteral administration and their use |
| 03/03/1992 | CA1296623C Aids prognosis test |
| 03/01/1992 | WO1992004459A1 Macrophage activating factor from vitamin d binding protein |
| 03/01/1992 | WO1992004455A1 Multidomain hematopoiesis stimulators |
| 03/01/1992 | WO1992004377A1 HUMAN INTERFERON-η4-134, FUNCTIONAL EQUIVALENTS THEREOF AND METHODS OF USING AND COMPOSITIONS EMPLOYING THESE MATERIALS |
| 03/01/1992 | WO1992004053A1 Homoconjugated immunoglobulins |
| 03/01/1992 | WO1992004046A1 Novel peptide antigens and immunoassays, test kits and vaccines using the same |
| 03/01/1992 | WO1992004034A1 Method for treating endotoxin shock using anti-adhesion antibodies |
| 03/01/1992 | WO1992003555A1 Mutation of hrv2 2a |
| 03/01/1992 | WO1992003471A1 New insulin-like growth factor binding protein igfbp-5 |
| 03/01/1992 | WO1992003470A1 Genetic material encoding igfbp-5 |
| 03/01/1992 | WO1992003469A1 Genetic material encoding igfbp-4 |
| 03/01/1992 | WO1992003152A1 New insulin-like growth factor binding protein (igfbp-4) |
| 03/01/1992 | CA2090705A1 Genetic material encoding igfbp-5 |
| 03/01/1992 | CA2090704A1 Genetic material encoding igfbp-4 |
| 03/01/1992 | CA2090703A1 Insulin-like growth factor binding protein (igfbp-4) |
| 03/01/1992 | CA2090702A1 Insulin-like growth factor binding protein igfbp-5 |
| 03/01/1992 | CA2090478A1 Human interferon- 4-134, functional equivalents thereof and methods of using and compositions employing these materials |
| 03/01/1992 | CA2090470A1 Peptide antigens and immunoassays, test kits and vaccines using the same |
| 03/01/1992 | CA2090464A1 Method for treating endotoxin shock using anti-adhesion antibodies |
| 03/01/1992 | CA2090317A1 Homoconjugated immunoglobulins |
| 03/01/1992 | CA2072105A1 Mutation of hrv2 2a |
| 03/01/1992 | CA2050451A1 Dna and polypeptide for tumor-associated antigen co-029 |
| 03/01/1992 | CA2050092A1 Amino acid derivatives |